Skip to main content


Fig. 6 | Cell Communication and Signaling

Fig. 6

From: Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma

Fig. 6

Application of the signature across diffuse gliomas in CGGA database. a-c Survival analysis of the four subgroups stratified according to risk signature and MGMT promoter methylation status across diffuse gliomas. d-e Survival distribution and Kaplan-Meier plots for OS of GBM patients with chemotherapy. f GSEA analysis based on the median value of risk score in GBM patients with chemotherapy

Back to article page